Sweden is dependent on new, innovative development-based companies, which can become future growth companies. Interest from private financing of early-stage companies is usually low as it involves high-risk investments. Vinnova has established several funds for start-ups and early-stage companies: VINN-NU is one of the programs. 150 companies applied, 15 companies were selected, and three of them were life science companies. One of them was Ten Medical Design (10MD) in Gothenburg. Β 

"With the help of this highly prestigious fund from Vinnova, we will continue our strategic plan towards commercializing a new material for radiation safety protection products," says Fredrik Gellerstedt, one of the founders of 10MD.


Vinnova press release, 2013-06-17

Life Science Sweden, press release, 2013-06-18

GΓΆteborgBIO, press release, 2013-06-24

Innovationskontor VΓ€st, Chalmers University of Technology, 2013-06-24